Monaco Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-120,000
Closed -$1.21M 101
2025
Q1
$1.21M Sell
120,000
-15,000
-11% -$162K 0.25% 45
2024
Q4
$1.6M Buy
135,000
+35,000
+35% +$414K 0.23% 47
2024
Q3
$1.15M Buy
100,000
+60,000
+150% +$683K 0.17% 54
2024
Q2
$423K Buy
+40,000
New +$438K 0.07% 57

Other funds holding ROIV

Monaco Asset Management's ROIV Position: Q2 2025 in Review

Monaco Asset Management sold out of Roivant Sciences (ROIV) in Q2 2025, closing a stake of 120,000 shares — an estimated $1.21M sold.

Monaco Asset Management first reported a position in ROIV in Q2 2024 and held it in 4 quarters. The position peaked at $1.6M in Q4 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q2 2025.

  • Monaco Asset Management reported no remaining Roivant Sciences position as of Q2 2025 after selling out during the quarter.
  • Monaco Asset Management sold 120,000 Roivant Sciences shares in Q2 2025, an estimated $1.21M.
  • Monaco Asset Management first reported a position in Roivant Sciences in Q2 2024 and held it in 4 quarters.
  • Monaco Asset Management's Roivant Sciences position peaked at $1.6M in Q4 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2025.

Based on Monaco Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.